Australien - engelsk - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - clomifene citrate -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: monobasic sodium phosphate monohydrate; dibasic sodium phosphate dihydrate; sucrose - azacitidine-teva is indicated for the treatment of patients with: intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), chronic myelomonocytic leukemia [cmmol (10 percent-29 percent marrow blasts without myeloproliferative disorder)], acute myeloid leukemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - clomifene citrate, quantity: 50 mg - tablet, uncoated - excipient ingredients: sucrose; lactose monohydrate; maize starch; magnesium stearate; pregelatinised maize starch; iron oxide yellow - indications as at 1 january 1991: clomid is indicated for the treatment of ovarian failure in carefully selected infertile women who wish to become pregnant.

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agnova technologies pty ltd - metham present as sodium salt - aqueous concentrate - metham present as sodium salt carbamate-dithiocarbamate active 423.0 g/l - mixed function pesticide - lawn | limited area | potting soil - floriculture & ornamental | seedbed | tobacco plant bed - club root of crucifers | fat hen | fungal diseases - see label | fusarium soil fungus | nematode - soil borne plant parasitic | onion weed | phytophthora soil fungus | prince of wales feather | pythium spp. | rhizoctonia | sclerotinia rot | symphylid | verticillium wilt | weed seed - see label | winter grass | amaranthus cruentus | amaranthus powellii | amaranthus viridis | annual blue grass | annual poa | asphodel | club root of crucifers | fat hen | fusarium | garden centipedes | goose grass | grease spot | onion grass | phytophthora | prince of wales feather | ptilotus exaltus | pythium | pythium blight | rhizoctonia | sclerotinia | sclerotinia flower blight | sclerotinia fungal disease | sclerotinia root rot | sclerotinia soil fungus | soil fungi | symphylans | verticillium | verticillium dahliae | verticillium soil fungus | weed seeds | white goosefoot | white mould | wild onion | wilt - sclerotinia | winter grass

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

therabody australia pty ltd - 44768 - compression system stocking/sleeve/suit, multi-chamber, reusable - the recovery pump powered inflatable massager is indicated for the temporary relief of minor aches & pains and for temporary increase in circulation in the treated areas of people who are in good health. the recovery pump simulates the kneading & stroking of tissues by an inflatable garment

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nu-cans australia pty. ltd. - piperonyl butoxide; pyrethrum - aerosol - piperonyl butoxide benzodioxole active 60.0 g/kg; pyrethrum pyrethroid-pyrethrum active 14.0 g/kg - insecticide - barn | club | dairy or milking shed | domestic and/or public area | food preparation and/or storage area | hospital | hotel and/ - ant | cockroach | crawling insect | flea | fly | flying insect | mosquito | moth | adult | adult mosquitoes | ants | argentine ant | cockroachs | ctenocephalides spp. | fleas | flies | ground fleas | large cockroach | mosquitoes | moths | pharaoh ant | silverfish | small cockroach

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

merck serono australia pty ltd - clomiphene citrate -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cytarabine -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - flecainide acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; hydrogenated vegetable oil; magnesium stearate; croscarmellose sodium; pregelatinised maize starch - supraventricular arrhythmias: (a) due to pre-excitation syndromes, eg wolff-parkinson-white and lown-ganong-levine syndromes. (b) due to dual av nodal pathways in patients with debilitating symptoms. (c) paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms. although tambocor may be effective in supraventricular arrhythmias in patients with structural heart disease, its use has been associated with life threatening and occasionally fatal ventricular arrhythmias. in these patients, particularly in the presence of impaired left ventricular function, tambocor should be used with extreme caution, preferably after other antiarrhythmic drugs have been tried or considered inappropriate. use of tambocor in chronic atrial fibrillation has not been adequately studied and is not recommended. 2. life threatening ventricular arrhythmias not controlled by other drugs. intravenous tambocor is indicated when rapid control or short-term prophylaxis of the above arrhythmias is the main clinical requir

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - flecainide acetate, quantity: 50 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; hydrogenated vegetable oil; magnesium stearate; pregelatinised maize starch - supraventricular arrhythmias: (a) due to pre-excitation syndromes, eg wolff-parkinson-white and lown-ganong-levine syndromes. (b) due to dual av nodal pathways in patients with debilitating symptoms. (c) paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms. although tambocor may be effective in supraventricular arrhythmias in patients with structural heart disease, its use has been associated with life threatening and occasionally fatal ventricular arrhythmias. in these patients, particularly in the presence of impaired left ventricular function, tambocor should be used with extreme caution, preferably after other antiarrhythmic drugs have been tried or considered inappropriate. use of tambocor in chronic atrial fibrillation has not been adequately studied and is not recommended. 2. life threatening ventricular arrhythmias not controlled by other drugs. intravenous tambocor is indicated when rapid control or short-term prophylaxis of the above arrhythmias is the main clinical requir